Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances

Daily Values

Growth Metrics

Casella Waste Systems (CWST) Asset Writedowns and Impairment (2018)

Casella Waste Systems' Asset Writedowns and Impairment history spans 3 years, with the latest figure at $311000.0 for Q1 2018.

For Q1 2018, Asset Writedowns and Impairment changed N/A year-over-year to $311000.0; the TTM value through Dec 2018 reached $311000.0, changed N/A, while the annual FY2018 figure was $311000.0, N/A changed from the prior year.
Asset Writedowns and Impairment reached $311000.0 in Q1 2018 per CWST's latest filing, up from -$221000.0 in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $311000.0 in Q1 2018 to a low of -$221000.0 in Q4 2015.